4,871 research outputs found
PRECLINICAL RATIONALE FOR THE USE OF THE AKT INHIBITOR PERIFOSINE IN COMBINATION WITH THE MULTIKINASE INHIBITOR SORAFENIB IN HODGKIN LYMPHOMA
INTRODUCTION: A significant proportion of Hodgkin lymphoma (HL) patients refractory to first-line chemotherapy or relapsing after autologous transplantation are not cured with currently available treatments and require new treatments. The PI3K/AKT and RAF/MEK/ERK pathways are constitutively activated in the majority of HL. These pathways can be targeted using the AKT inhibitor perifosine (\uc6terna Zentaris GmBH, Germany, EU), and the RAF/MEK/ERK inhibitor sorafenib (Nexavar\uae, Bayer, Germany, EU). We hypothesized that perifosine in combination with sorafenib might have a therapeutic activity in HL by overcoming the cytoprotective and anti-apoptotic effects of PI3K/Akt and RAF/MEK/ERK pathways. Since preclinical evidence supporting the anti-lymphoma effects of the perifosine/sorafenib combination are still lacking, the present study aimed at investigating in vitro and in vivo the activity and mechanism(s) of action of this two-drug combination.
METHODS: Three HL cell lines (HD-MyZ, L-540 and HDLM-2) were used to investigate the effects of perifosine and sorafenib using in vitro assays analyzing cell growth, cell cycle distribution, gene expression profiling (GEP), and apoptosis. Western blotting (WB) experiments were performed to determine whether the two-drug combination affected MAPK and PI3K/AKT pathways as well as apoptosis. Additionally, the antitumor efficacy and mechanism of action of perifosine/sorafenib combination were investigated in vivo in nonobese diabetic/severe combined immune-deficient (NOD/SCID) mice using tumor growth rates and survival as endpoints.
RESULTS: While perifosine and sorafenib as single agents exerted a limited activity against HL cells, exposure of HD-MyZ and L-540 cell lines, but not HDLM-2 cells, to perifosine/sorafenib combination resulted in synergistic cell growth inhibition (40% to 80%) and cell cycle arrest. Upon perifosine/sorafenib exposure, L-540 cell line showed significant levels of apoptosis (up to 70%, P 64.0001) associated with severe mitochondrial dysfunction (cytochrome c, apoptosis-inducing factor release and marked conformational change of Bax accompanied by membrane translocation). Apoptosis induced by perifosine/sorafenib combination did not result in processing of caspase-8, -9, -3, or cleavage of PARP, and was not reversed by the pan-caspase inhibitor Z-VADfmk, supporting a caspase-independent mechanism of apoptosis. In responsive cell lines, WB analysis showed that anti-proliferative events were associated with dephosphorylation of MAPK and PI3K/Akt pathways. GEP analysis of HD-MyZ and L-540 cell lines, but not HDLM-2 cells indicated that perifosine/sorafenib treatment induced upregulation of genes involved in amino acid metabolism and downregulation of genes regulating cell cycle, DNA replication and cell death. In addition, in responsive cell lines, perifosine/sorafenib combination strikingly induced the expression of tribbles homologues 3 (TRIB3) both in vitro and in vivo. Silencing of TRIB3 prevented cell growth reduction induced by perifosine/sorafenib treatment. In vivo, the combined perifosine/sorafenib treatment significantly increased the median survival of NOD/SCID mice xenografted with HD-MyZ cell line as compared to controls (81 vs 45 days, P 64.0001) as well as mice receiving perifosine alone (49 days, P 64.03) or sorafenib alone (54 days, P 64.007). In addition, perifosine/sorafenib treatment had no effect on HDLM-2 nodules, but significantly reduced L-540 nodules with 50% tumor growth inhibition (P 64.0001), compared to controls. In mice bearing subcutaneous nodules generated by HD-MyZ and L-540 cell lines but not HDLM-2 cell line, perifosine/sorafenib treatment induced significantly increased levels of apoptosis (2- to 2.5-fold, P 64.0001) and necrosis (2- to 8-fold, P 64.0001), as compared to controls or treatment with single agents.
CONCLUSIONS: Perifosine/sorafenib combination resulted in potent anti-HL activity both in vitro and in vivo. These results warrant clinical evaluation in HL patients
ADAR enzyme and miRNA story: A nucleotide that can make the difference
Adenosine deaminase acting on RNA (ADAR) enzymes convert adenosine (A) to inosine (I) in double-stranded (ds) RNAs. Since Inosine is read as Guanosine, the biological consequence of ADAR enzyme activity is an A/G conversion within RNA molecules. A-to-I editing events can occur on both coding and non-coding RNAs, including microRNAs (miRNAs), which are small regulatory RNAs of ~20-23 nucleotides that regulate several cell processes by annealing to target mRNAs and inhibiting their translation. Both miRNA precursors and mature miRNAs undergo A-to-I RNA editing, affecting the miRNA maturation process and activity. ADARs can also edit 3' UTR of mRNAs, further increasing the interplay between mRNA targets and miRNAs. In this review, we provide a general overview of the ADAR enzymes and their mechanisms of action as well as miRNA processing and function. We then review the more recent findings about the impact of ADAR-mediated activity on the miRNA pathway in terms of biogenesis, target recognition, and gene expression regulation
Children and fecal SARS-CoV-2 shedding: just the tip of the Iceberg of italian COVID-19 outbreak?
A produção orgânica no municÃpio de Cacoal, RO: uma análise da dinâmica econômica e o desenvolvimento sustentável.
A preocupação com a segurança alimentar, qualidade de vida e a questão ambiental vem ao longo do tempo adquirindo uma dinâmica em escala global com novos hábitos alimentares e modos de produção. Com o objetivo verificar o desenvolvimento produtivo e sua viabilidade comercial diante da implantação de sistemas orgânicos na associação dos produtores do municÃpio de Cacoal, RO buscou-se analisar e caracterizar as relações comerciais e sociais que se estabelece entre o produtor e consumidor sendo identificados os diferentes cenários como: produção, distribuição e comercialização no municÃpio, através do método de pesquisa com a identificação dos principais meios e espaços de comercialização e, a realização de entrevistas com os principais membros da associação e feirante envolvidos no processo. Conclui-se que diante dos obstáculos a serem superados, a produção e a comercialização agroecológica apresenta possibilidades de expansão no municÃpio
Modulation of microRNA editing, expression and processing by ADAR2 deaminase in glioblastoma.
Background: ADAR enzymes convert adenosines to inosines within double-stranded RNAs, including microRNA
(miRNA) precursors, with important consequences on miRNA retargeting and expression. ADAR2 activity is impaired
in glioblastoma and its rescue has anti-tumoral effects. However, how ADAR2 activity may impact the miRNome
and the progression of glioblastoma is not known.
Results: By integrating deep-sequencing and array approaches with bioinformatics analyses and molecular studies,
we show that ADAR2 is essential to edit a small number of mature miRNAs and to significantly modulate the
expression of about 90 miRNAs in glioblastoma cells. Specifically, the rescue of ADAR2 activity in cancer cells recovers
the edited miRNA population lost in glioblastoma cell lines and tissues, and rebalances expression of onco-miRNAs and
tumor suppressor miRNAs to the levels observed in normal human brain. We report that the major effect of ADAR2 is
to reduce the expression of a large number of miRNAs, most of which act as onco-miRNAs. ADAR2 can edit miR-222/221
and miR-21 precursors and decrease the expression of the corresponding mature onco-miRNAs in vivo and in vitro, with
important effects on cell proliferation and migration.
Conclusions: Our findings disclose an additional layer of complexity in miRNome regulation and provide information
to better understand the impact of ADAR2 editing enzyme in glioblastoma. We propose that ADAR2 is a key factor for
maintaining edited-miRNA population and balancing the expression of several essential miRNAs involved in cancer
Agroforestry systems in Brazilian Amazon: socioeconomic and geo-environment aspects in the Ariquemes region, state of Rondônia.
Human leucocyte antigen diversity: a biological gift to escape infections, no longer a barrier for haploidentical hemopoietic stem cell transplantation
Since the beginning of life, every multicellular organism appeared to have a complex innate immune system although the adaptive immune system, centred on lymphocytes bearing antigen receptors generated by somatic recombination, arose in jawed fish approximately 500 million years ago. The major histocompatibility complex MHC, named the Human leucocyte antigen (HLA) system in humans, represents a vital function structure in the organism by presenting pathogen-derived peptides to T cells as the main initial step of the adaptive immune response. The huge level of polymorphism observed in HLA genes definitely reflects selection, favouring heterozygosity at the individual or population level, in a pathogen-rich environment, although many are located in introns or in exons that do not code for the antigen-biding site of the HLA. Over the past three decades, the extent of allelic diversity at HLA loci has been well characterized using high-resolution HLA-DNA typing and the number of new HLA alleles, produced through next-generation sequencing methods, is even more rapidly increasing. The level of the HLA system polymorphism represents an obstacle to the search of potential compatible donors for patients affected by haematological disease proposed for a hematopoietic stem cell transplant (HSCT). Data reported in literature clearly show that antigenic and/or allelic mismatches between related or unrelated donors and patients influences the successful HSCT outcome. However, the recent development of the new transplant strategy based on the choice of haploidentical donors for HSCT is questioning the role of HLA compatibility, since the great HLA disparities present do not worsen the overall clinical outcome. Nowadays, NGS has contributed to define at allelic levels the HLA polymorphism and solve potential ambiguities. However, HLA functions and tissue typing probably need to be further investigated in the next future, to understand the reasons why in haploidentical transplants the presence of a whole mismatch haplotype between donors and recipients, both the survival rate and the incidence of acute GvHD or graft rejection are similar to those reported for unrelated HSCTs
Estudo preliminar de sistemas agroflorestais no Distrito de Triunfo, Candeias do Jamari, Rondônia.
O presente estudo teve por objetivo conhecer/analisar experiências em sistemas agroflorestais no Distrito de Triunfo, MunicÃpio de Candeias do Jamari, Rondônia, identificando os tipos de sistemas implantados, as perspectivas dos produtores quanto aos SAF, bem como evidenciar dados para estimular outros produtores a aderirem à prática de sistemas agroflorestais
- …